Rxsight Inc (RXST) support and resistance · rev $139.9M
Rxsight Inc (RXST) is a medical devices company listed on NASDAQ.
This page maps Rxsight Inc (RXST) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported RXST revenue for 2024-12-31 was $139.9M. Net income was -$27.5M. Revenue was up 57.1% from 2023-12-31 to 2024-12-31. RXST currently screens at market cap $198.3M.
RXST currently screens at market cap $198.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new RXST 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the RXST quote page for the session range and the stock page for the full model.
Not investment advice.